Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)
Clinical trial NCT06162728 · COMPLETED
Trial details
- NCT number
- NCT06162728
- Sponsor
- Jasper Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-29
- Primary completion
- 2026-07-08
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.